GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Avalon Globocare Corp (NAS:ALBT) » Definitions » Enterprise Value

ALBT (Avalon Globocare) Enterprise Value : $34.61 Mil (As of Apr. 27, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Avalon Globocare Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Avalon Globocare's Enterprise Value is $34.61 Mil. Avalon Globocare's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $-5.47 Mil. Therefore, Avalon Globocare's EV-to-EBIT ratio for today is -6.33.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Avalon Globocare's Enterprise Value is $34.61 Mil. Avalon Globocare's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was $-5.17 Mil. Therefore, Avalon Globocare's EV-to-EBITDA ratio for today is -6.70.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Avalon Globocare's Enterprise Value is $34.61 Mil. Avalon Globocare's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was $1.33 Mil. Therefore, Avalon Globocare's EV-to-Revenue ratio for today is 25.95.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Avalon Globocare's Enterprise Value is $34.61 Mil. Avalon Globocare's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was $-4.97 Mil. Therefore, Avalon Globocare's EV-to-FCF ratio for today is -6.97.


Avalon Globocare Enterprise Value Historical Data

The historical data trend for Avalon Globocare's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avalon Globocare Enterprise Value Chart

Avalon Globocare Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 95.24 75.06 63.37 33.53 33.19

Avalon Globocare Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.53 31.66 33.49 31.11 33.19

Competitive Comparison of Avalon Globocare's Enterprise Value

For the Real Estate Services subindustry, Avalon Globocare's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avalon Globocare's Enterprise Value Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, Avalon Globocare's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Avalon Globocare's Enterprise Value falls into.


;
;

Avalon Globocare Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Avalon Globocare's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as

Avalon Globocare's Enterprise Value for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avalon Globocare  (NAS:ALBT) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Avalon Globocare's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=34.611/-5.467
=-6.33

Avalon Globocare's current Enterprise Value is $34.61 Mil.
Avalon Globocare's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.47 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Avalon Globocare's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=34.611/-5.166
=-6.70

Avalon Globocare's current Enterprise Value is $34.61 Mil.
Avalon Globocare's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.17 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Avalon Globocare's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=34.611/1.334
=25.95

Avalon Globocare's current Enterprise Value is $34.61 Mil.
Avalon Globocare's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.33 Mil.

4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Avalon Globocare's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=34.611/-4.969
=-6.97

Avalon Globocare's current Enterprise Value is $34.61 Mil.
Avalon Globocare's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.97 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avalon Globocare Enterprise Value Related Terms

Thank you for viewing the detailed overview of Avalon Globocare's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Avalon Globocare Business Description

Traded in Other Exchanges
N/A
Address
4400 Route 9 South, Suite 3100, Freehold, NJ, USA, 07728
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
Executives
Lourdes Felix director 15 CALLE VERANO, RANCHO SANTA MARGARITA CA 92688
W J Tauzin director 901 HUGH WALLIS ROAD S, LAFAYETTE LA 70508
Wenzhao Lu director, 10 percent owner C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Steven Andrew Sanders director 431 EAST 20TH STREET, NEW YORK NY 10010
Yancen Lu director 14009 SE 50TH STREET, BELLEVUE WA 98006
Stilley William B. Iii director 1180 SEMINOLE TRAIL, SUITE 495, CHARLOTTESVILLE VA 22901
Tevi Troy director 611 SOMERSWORTH WAY, SILVER SPRING MD 20902
Luisa Ingargiola officer: Chief Financial Officer 4826 BLUE JAY CIRCLE, PALM HARBOR FL 34683
David Jin director, officer: CEO and President C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Yue Charles Li director C/O AVALON GLOBOCARE CORP., 4400 ROUTE 9 SOUTH, SUITE 3100, FREEHOLD NJ 07728
Meng Li director, officer: Chief Operating Officer C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Steven Philip Sukel director 33 ALPINE DRIVE, MORGANVILLE NJ 07751